Park Medi World Ltd

Park Medi World Ltd has announced the incorporation of its wholly owned subsidiary, Park Medicity Prayagraj Limited, on September 08, 2026. This new entity will focus on the healthcare sector, specifically for the development and operation of a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. The project is being undertaken under a Public-Private Partnership (PPP) model with the Prayagraj Municipal Corporation. The initial investment for this subsidiary is Rs. 0.15 crore, comprising 1,50,000 equity shares. The company has acquired 100% shareholding in the newly incorporated entity.

Park Medi World Limited has approved the incorporation of a wholly-owned subsidiary, tentatively named 'Park Medicity Prayagraj Limited' or 'Park Hospital Prayagraj Limited', to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. This initiative is part of a Public-Private Partnership (PPP) model awarded by the Prayagraj Municipal Corporation. The subsidiary will be established with an initial investment of INR 0.15 crore, comprising 1,50,000 equity shares. The company will hold 100% shareholding in this new entity, which will operate within the healthcare services sector.

Park Medi World Limited announced that its Board of Directors has approved the incorporation of a wholly-owned subsidiary, to be named "Park Medicity Prayagraj Limited" or "Park Hospital Prayagraj Limited", or similar, as a Special Purpose Vehicle. This subsidiary will be responsible for the development and operation of a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, under a Public-Private Partnership (PPP) model with the Prayagraj Municipal Corporation. The incorporation is a step following the company's winning bid for this project. The subsidiary will be incorporated in India and will operate in the healthcare services sector. The cost of subscription for the subsidiary's shares is INR 0.15 crore, comprising 1,50,000 equity shares.

Park Medi World Ltd has dispatched letters to shareholders without registered email IDs, providing a weblink to access the Annual Report for FY 2025-26. The 15th Annual General Meeting (AGM) is scheduled for September 22, 2026, to be held via Video Conferencing. The Notice of AGM and Annual Report have been sent via email to shareholders whose addresses were registered by August 21, 2026. Remote e-voting will be open from September 18 to September 21, 2026. Shareholders are encouraged to register their email IDs for seamless communication.

Park Medi World Ltd has announced its 15th Annual General Meeting (AGM) scheduled for September 22, 2026. The company has released its Annual Report for the Financial Year 2025-26, which includes the AGM notice and statutory reports. The report is being sent electronically to shareholders and is also available on the company's website. The AGM will facilitate remote e-voting and e-voting during the meeting, with a cut-off date of September 15, 2026, for voting rights. Remote e-voting will be open from September 18 to September 21, 2026. The report highlights the company's growth, expansion in affordable healthcare, and its presence across North India with 17 multi-super specialty hospitals and 4,290 beds.

Park Medi World Ltd has announced its 15th Annual General Meeting (AGM) will be held on Tuesday, September 22, 2026, at 11:00 AM IST. The meeting will be conducted through video conference/other audio-visual means, in compliance with MCA and SEBI circulars. The company has also dispatched its Annual Report for FY 2025-26, including the AGM notice, to shareholders electronically. Shareholders can access the report and notice online. Remote e-voting will be available from September 18 to September 21, 2026. The cut-off date for voting eligibility is September 15, 2026.

Park Medi World Ltd has secured a mandate from Prayagraj Municipal Corporation, Uttar Pradesh, to develop and operate a 550-bed multi-super-speciality hospital under a Public-Private Partnership (PPP) model. The project involves an investment of approximately INR 200 crore, with INR 76.52 crore being reimbursed by the State Government. The hospital will be constructed over two years from the appointed date and operated under a long-term lease of 45 years. This expansion aims to cater to the growing healthcare needs of the Prayagraj region and reinforces Park Group's presence in Uttar Pradesh, a state identified as underserved in healthcare infrastructure.

Park Medi World Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of its Initial Public Offering (IPO) proceeds. The report, issued by CRISIL Ratings Limited, confirms that the utilization of funds is in line with the disclosures made in the Offer Document. The company's Board of Directors and Audit Committee have reviewed and considered this report. The IPO, which raised ₹7,700 million, had net proceeds of ₹7,132.77 million after issue expenses. The company has also made this disclosure available on its website.

Park Medi World Ltd. announced its unaudited Q1 FY'27 results, reporting a strong year-on-year growth of 19% in revenue to INR 4,757 million and a 35% increase in net profit to INR 886 million. EBITDA also saw a 20% rise to INR 1,261 million. The company is executing its largest capacity expansion, planning to add 1,490 beds in calendar year 2026, a 46% increase over 2025 capacity. This expansion is being funded from a balance sheet with negligible term debt and strong liquidity. Key growth drivers include the commissioning of a new hospital in Panchkula, the acquisition of 'The Medicity Hospital' in Rudrapur, expansion of its Palam Vihar facility, and the agreement to acquire 'Mehar Hospital' in Zirakpur. The company aims to integrate acquired assets, improve utilization, and sustain profitability.

Park Medi World Limited announced the approval of the acquisition of Mehar Hospital-Zirakpur, owned and operated by Mehar Mediserve LLP. This decision was made during the Board of Directors meeting held on August 3, 2026. The company also approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, a variation in the objects of the Initial Public Offer Proceeds was considered, subject to shareholder approval via postal ballot. The acquisition details are provided as per SEBI circulars.